BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 16, 2005
View Archived Issues
GAD: Spotlight on patients that "worry themselves sick"
Read More
Roche profiles successful quarter
Read More
Recordati licenses Stanate from InfaCare
Read More
Cardio Vascu-Grow shows preclinical potential for peripheral vascular disease
Read More
Enzo acquires rights to drug candidate for treating uveitis
Read More
Trimeris, ChemBridge Research Laboratories to develop HIV entry inhibitors
Read More
Orphan drug designation for Vical's CMV DNA vaccine
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
Profiling of recombinant human IGF-1 treatment
Read More
New therapeutics claimed for diabetes
Read More
Gallium maltolate demonstrates in vivo efficacy for RA
Read More
Mechanisms underlying new apoptosis-inducing agents developed by Maxim
Read More
Recent patents reveal new agents for hepatitis treatment
Read More
Cinacalcet reported effective in hyperparathyroidism after renal transplantation
Read More
Update on everolimus in the prevention of allograft rejection
Read More
Hematological changes reported for CC-4047 in multiple myeloma patients
Read More
Promising results found for inolimumab in steroid-resistant aGvHD
Read More
Scios convenes panel of cardiology experts to review Natrecor
Read More
Miraxion enters phase III trial for Huntington's disease
Read More
Exelixis submits IND for XL-184
Read More
Medarex and Boehringer Ingelheim enter antibody development agreement
Read More
Metabolic receives grant for phase I trial of ACV-1 for neuropathic pain
Read More
Expanded access program planned for protease inhibitor TMC-114
Read More
Indiplon capsules NDA accepted for review
Read More
Merck KGaA wins patent appeal
Read More
NDS filed for Abraxane in Canada
Read More
Mylan plans to outlicense nebivolol
Read More
